Clinical Trials Logo

Clinical Trial Summary

To compare the single-dose bioavailability of Par and Bristol-Myers Squibb Buspirone HCl Tablets


Clinical Trial Description

To compare the single-dose bioavailability of Par and Bristol-Myers Squibb (Buspar) 15 mg buspirone HCl tablets, following administration of a 30 mg dose, under fed conditions. In addition, the bioavailability of the Par product was compared under fed and fasting conditions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00652730
Study type Interventional
Source Par Pharmaceutical, Inc.
Contact
Status Completed
Phase Phase 1
Start date July 1998
Completion date September 1998

See also
  Status Clinical Trial Phase
Completed NCT00652600 - Bioavailability Study of Propranolol Under Fed Conditions Phase 1
Completed NCT01380496 - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions Phase 1
Completed NCT00652821 - Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions Phase 1
Completed NCT00652873 - Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions Phase 1
Completed NCT00652704 - Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions Phase 1
Completed NCT05329857 - The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated. N/A
Completed NCT05337969 - The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed. N/A
Completed NCT00653003 - Bioavailability Study of Leflunomide Tablets Under Fed Conditions Phase 1
Completed NCT01380431 - A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study Phase 1